Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii
Yannick Charretier(Institut Mérieux (France)), Seydina M. Diene(University Hospital of Geneva), Damien Baud(University Hospital of Geneva), Sonia Chatellier(Institut Mérieux (France)), Emmanuelle Santiago-Allexant(bioMérieux (France)), Alex van Belkum(Institut Mérieux (France)), Ghislaine Guigon(bioMérieux (France)), Jacques Schrenzel(University Hospital of Geneva)
Cited by 78Open Access
Abstract
Multidrug-resistant Acinetobacter baumannii infection has recently emerged as a worldwide clinical problem, and colistin is increasingly being used as a last-resort therapy. Despite its favorable bacterial killing, resistance and heteroresistance (HR) to colistin have been described.
Related Papers
No related papers found
Powered by citation graph analysis